SHAPE Honors Director of the Framingham Heart Study and University of Virginia Professor for Achievements in Heart Attack Prevention

Share Article

Dr. Valentin Fuster, presents Dr. Daniel Levy of Framingham Heart Study and Dr. Kamwe Akosah of University of Virginia the SHAPE Lifetime Achievement Award during the event; "Approaches to SHAPE the future of Primary Prevention: The New Framingham Risk Score and Beyond," held on March 29, 2008 at the Westin Hotel on Michigan Ave. in Chicago. The program will cover the evolution of Framingham Risk Scoring and proposed multimodality approaches for cardiovascular risk assessment, it will be moderated by Drs. Roger Blumenthal, Morteza Naghavi and P.K. Shah.

Heart disease kills more Americans every year than any other cause of death

The Society for Heart Attack Prevention and Eradication (SHAPE) announced this year's recipients of the organization's Lifetime Achievement Award.

Dr. Dan Levy, the director of the Framingham Heart Study and Dr. Kawme Akosah, an associate professor of Medicine at the University of Virginia School of Medicine will be honored during the SHAPE Symposium held on March 29, 2008, a satellite event to the American College of Cardiology's annual convention. SHAPE's prestigious honor is reserved only for those individuals whose work includes substantial contributions to the field of preventive cardiology.

"The pioneering Framingham Heart Study built the foundation of preventive cardiology," said Dr. Morteza Naghavi, Chairman of SHAPE. "We honor all investigators who contributed to the Study. Dr. Levy in particular has contributed the most to raising public awareness and education about the Framingham Heart Study and its discoveries. Dr. Akosah's work is also tremendously valuable, because it has brought to light the gaps that exist in current cardiovascular risk assessment. SHAPE is pleased to honor both of these outstanding physician-researchers."

"It is important to emphasize that the SHAPE Guideline is not a replacement for the Framingham Risk Score," said Dr. PK Shah, Chief of Cardiology at Cedars Sinai Medical Center and a member of SHAPE Board of Directors. "On the contrary, the SHAPE guideline is complimentary to the traditional Framingham risk assessment since it calls for additional testing to identify subclinical atherosclerosis only after the Framingham score is considered."

The award ceremony will take place after the organizations satellite symposium. The event; Approaches to SHAPE the future of Primary Prevention: The New Framingham Risk Score and Beyond, will be at the Westin Hotel on Michigan Ave. in Chicago. Registration is free for academia from accredited cardiology programs and members of the media.    

"Heart disease kills more Americans every year than any other cause of death," said Dr. Roger Blumenthal, Director of the Johns Hopkins Ciccarone Center for Prevention of Heart Disease. "Exploring new methodologies and promoting responsible use of proven technologies is the most logical solution to this problem."

Coronary heart disease has remained the number one killer in the United States since 1902. In response, SHAPE is calling for certain asymptomatic individuals -- especially those with a family member who has suffered a cardiac event -- to undergo noninvasive screening in combination with their Framingham Risk Score to determine their individual risk.

Modeled after successful cancer screening efforts, the SHAPE Guideline calls for asymptomatic and apparently healthy men 45-75 years and women 55-75 years to undergo screening to assess coronary artery plaque or carotid wall thickness. It recommends the coronary artery calcium scan (Heart Scan) or carotid scan (Carotid IMT) - two tests that have proven to be strong predictors of those who are vulnerable to a heart attack or stroke. Preventive exams give healthcare professionals the opportunity to take appropriate action before fatal symptoms appear.


SHAPE's mission is to eradicate heart attack by promoting effective tools for prevention while advancing the scientific quest for a cure. Additional information is available on the organization's website: or call 877-SHAPE11.


Share article on social media or email:

View article via:

Pdf Print